nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—Urinary hesitation—Fludarabine—lymphatic system cancer	0.0357	0.0357	CcSEcCtD
Promethazine—Extravasation—Teniposide—lymphatic system cancer	0.0191	0.0191	CcSEcCtD
Promethazine—Thrombophlebitis—Mechlorethamine—lymphatic system cancer	0.0189	0.0189	CcSEcCtD
Promethazine—Sensory loss—Fludarabine—lymphatic system cancer	0.0169	0.0169	CcSEcCtD
Promethazine—Phlebitis—Teniposide—lymphatic system cancer	0.014	0.014	CcSEcCtD
Promethazine—Coma—Fludarabine—lymphatic system cancer	0.0134	0.0134	CcSEcCtD
Promethazine—Paralysis—Vincristine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Promethazine—Depression—Mechlorethamine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Promethazine—Phlebitis—Fludarabine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Promethazine—Jaundice—Mechlorethamine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Promethazine—Extravasation—Bleomycin—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Promethazine—Necrosis—Carmustine—lymphatic system cancer	0.0119	0.0119	CcSEcCtD
Promethazine—Abscess—Carmustine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Promethazine—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Promethazine—Necrosis—Mitoxantrone—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Promethazine—Extravasation—Carmustine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Promethazine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Promethazine—Sensory loss—Vincristine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Promethazine—Extravasation—Vincristine—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Promethazine—Extravasation—Mitoxantrone—lymphatic system cancer	0.00998	0.00998	CcSEcCtD
Promethazine—Coordination abnormal—Carmustine—lymphatic system cancer	0.00954	0.00954	CcSEcCtD
Promethazine—Injection site reaction—Carmustine—lymphatic system cancer	0.00931	0.00931	CcSEcCtD
Promethazine—Phlebitis—Bleomycin—lymphatic system cancer	0.00904	0.00904	CcSEcCtD
Promethazine—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00884	0.00884	CcSEcCtD
Promethazine—Appetite absent—Methotrexate—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Promethazine—Disorientation—Bleomycin—lymphatic system cancer	0.00871	0.00871	CcSEcCtD
Promethazine—Coma—Carmustine—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Promethazine—Coma—Vincristine—lymphatic system cancer	0.00817	0.00817	CcSEcCtD
Promethazine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00806	0.00806	CcSEcCtD
Promethazine—Phlebitis—Carmustine—lymphatic system cancer	0.00789	0.00789	CcSEcCtD
Promethazine—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00789	0.00789	CcSEcCtD
Promethazine—Thrombophlebitis—Carmustine—lymphatic system cancer	0.00786	0.00786	CcSEcCtD
Promethazine—Swelling—Carmustine—lymphatic system cancer	0.00771	0.00771	CcSEcCtD
Promethazine—Arrhythmia—Teniposide—lymphatic system cancer	0.00747	0.00747	CcSEcCtD
Promethazine—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Promethazine—Swelling—Mitoxantrone—lymphatic system cancer	0.00717	0.00717	CcSEcCtD
Promethazine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00701	0.00701	CcSEcCtD
Promethazine—Diplopia—Carmustine—lymphatic system cancer	0.0068	0.0068	CcSEcCtD
Promethazine—Agitation—Teniposide—lymphatic system cancer	0.00669	0.00669	CcSEcCtD
Promethazine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00657	0.00657	CcSEcCtD
Promethazine—Leukopenia—Teniposide—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Promethazine—Paralysis—Methotrexate—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Promethazine—Urinary retention—Vincristine—lymphatic system cancer	0.00617	0.00617	CcSEcCtD
Promethazine—Confusional state—Teniposide—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Promethazine—Oedema—Teniposide—lymphatic system cancer	0.00594	0.00594	CcSEcCtD
Promethazine—Agitation—Fludarabine—lymphatic system cancer	0.00588	0.00588	CcSEcCtD
Promethazine—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00582	0.00582	CcSEcCtD
Promethazine—Tachycardia—Teniposide—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Promethazine—Leukopenia—Fludarabine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Promethazine—Pruritus—Mechlorethamine—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Promethazine—Hypotension—Teniposide—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Promethazine—Convulsion—Fludarabine—lymphatic system cancer	0.00554	0.00554	CcSEcCtD
Promethazine—Necrosis—Methotrexate—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Promethazine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00551	0.00551	CcSEcCtD
Promethazine—Abscess—Methotrexate—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Promethazine—Confusional state—Fludarabine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Promethazine—Depression—Carmustine—lymphatic system cancer	0.00523	0.00523	CcSEcCtD
Promethazine—Oedema—Fludarabine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Promethazine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Promethazine—Decreased appetite—Teniposide—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Promethazine—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Promethazine—Apnoea—Methotrexate—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Promethazine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Promethazine—Rash—Mechlorethamine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Promethazine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Promethazine—Depression—Vincristine—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Promethazine—Extravasation—Methotrexate—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Promethazine—Feeling abnormal—Teniposide—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Promethazine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Promethazine—Jaundice—Mitoxantrone—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Promethazine—Erythema—Bleomycin—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Promethazine—Hallucination—Carmustine—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Promethazine—Dyspepsia—Fludarabine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Promethazine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Promethazine—Decreased appetite—Fludarabine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Promethazine—Fatigue—Fludarabine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Promethazine—Hallucination—Vincristine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Promethazine—Constipation—Fludarabine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Promethazine—Pain—Fludarabine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Promethazine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Promethazine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Promethazine—Asthenia—Teniposide—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Promethazine—Pruritus—Teniposide—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Promethazine—Arrhythmia—Carmustine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Promethazine—Leukopenia—Bleomycin—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Promethazine—Erythema—Carmustine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Promethazine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Promethazine—Diarrhoea—Teniposide—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Promethazine—Coma—Methotrexate—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Promethazine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Promethazine—Confusional state—Bleomycin—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Promethazine—Vision blurred—Carmustine—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Promethazine—Tremor—Carmustine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Promethazine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Promethazine—Oedema—Bleomycin—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Promethazine—Erythema—Mitoxantrone—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Promethazine—Agitation—Carmustine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Promethazine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Promethazine—Asthenia—Fludarabine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Promethazine—Rash—Teniposide—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Promethazine—Dermatitis—Teniposide—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Promethazine—Headache—Teniposide—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Promethazine—Pruritus—Fludarabine—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Promethazine—Leukopenia—Carmustine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Promethazine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Promethazine—Agitation—Vincristine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Promethazine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Promethazine—Photosensitivity—Methotrexate—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Promethazine—Hypotension—Bleomycin—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Promethazine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Promethazine—Convulsion—Carmustine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Promethazine—Leukopenia—Vincristine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Promethazine—Anxiety—Carmustine—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Promethazine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Promethazine—Convulsion—Vincristine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Promethazine—Confusional state—Carmustine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Promethazine—Oedema—Carmustine—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Promethazine—Decreased appetite—Bleomycin—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Promethazine—Convulsion—Mitoxantrone—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Promethazine—Rash—Fludarabine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Promethazine—Dermatitis—Fludarabine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Promethazine—Pain—Bleomycin—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Promethazine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Promethazine—Headache—Fludarabine—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Promethazine—Tachycardia—Carmustine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Promethazine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Promethazine—Oedema—Vincristine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Promethazine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Promethazine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Promethazine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Promethazine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Promethazine—Hypotension—Carmustine—lymphatic system cancer	0.00312	0.00312	CcSEcCtD
Promethazine—Oedema—Mitoxantrone—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Promethazine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Promethazine—Shock—Mitoxantrone—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Promethazine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Promethazine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Promethazine—Insomnia—Carmustine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Promethazine—Irritability—Methotrexate—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Promethazine—Hypotension—Vincristine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Promethazine—Somnolence—Carmustine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Promethazine—Decreased appetite—Carmustine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Promethazine—Hypotension—Mitoxantrone—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Promethazine—Insomnia—Vincristine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Promethazine—Constipation—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Promethazine—Pain—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Promethazine—Decreased appetite—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Promethazine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Promethazine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Promethazine—Fatigue—Vincristine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Promethazine—Asthenia—Bleomycin—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Promethazine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Promethazine—Constipation—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Promethazine—Pain—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Promethazine—Asthma—Methotrexate—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Promethazine—Pruritus—Bleomycin—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Promethazine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Promethazine—Fatigue—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Promethazine—Constipation—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Promethazine—Pain—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Promethazine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Promethazine—Depression—Methotrexate—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Promethazine—Rash—Bleomycin—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Promethazine—Dermatitis—Bleomycin—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Promethazine—Asthenia—Carmustine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Promethazine—Asthenia—Vincristine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Promethazine—Diarrhoea—Carmustine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Promethazine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Promethazine—Dizziness—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Promethazine—Diarrhoea—Vincristine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Promethazine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Promethazine—Dizziness—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Promethazine—Rash—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Promethazine—Dermatitis—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Promethazine—Headache—Carmustine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Promethazine—Rash—Vincristine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Promethazine—Dermatitis—Vincristine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Promethazine—Headache—Vincristine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Promethazine—Rash—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Promethazine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Promethazine—Headache—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Promethazine—Erythema—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Promethazine—Convulsion—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Promethazine—Confusional state—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Promethazine—Hypotension—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Promethazine—Insomnia—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Promethazine—Somnolence—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Promethazine—Fatigue—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Promethazine—Pain—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Promethazine—Asthenia—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Promethazine—Pruritus—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Promethazine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Promethazine—Dizziness—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Promethazine—Rash—Methotrexate—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Promethazine—Headache—Methotrexate—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
